Lower Manhattan-based Metsera is one of the latest drug startups to throw its hat into the ring with the pharma giants ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

The company's revenue jumped 77% in Q3 to reach $401.6 million in Q3 2024, alongside a net income of $75.6 million. It now ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

The Danish drugmaker and rival Eli Lilly have together sued dozens of medical spas, weight-loss clinics, compounding ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...